MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
8VC
Attachments
8VC | A different kind of VC firm.
Parents
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
2025: 'Hush hush' MAHA summit to feature RFK Jr., Vance and biotech leaders
2025: Top 100 venture investors in biotech_Biopharma Therapeutics, Platforms, Medtech, and Diagnostics _Where the money is_(ENDPOINTS NEWS)
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Venture Capital: Texas
Children
2017: An $11 million series A round in November 2017 had brought on Pillar Companies, Refactor Capital, 8VC, Danhua Capital and KdT Ventures as investors
2018: $33 million in Series A funding led by 8VC, with participation from Optum Ventures Alpha Edison and Heritage Provider Network
2019: The funding round was led by Redpoint Ventures with participation from 8VC, Echo Health Ventures, StartUp Health, Sidewalk Labs, Thrive Capital, Maverick Ventures, Town Hall Ventures and EmbelmHealth.
2019: The series B round was funded by BiomX’s previous backers, including OrbiMed, Johnson & Johnson Innovation and Takeda Ventures, as well as 8VC, MiraeAsset, Seventure Partners and the SBI Japan-Israel Innovation Fund.
2020: 8VC and Viking Global Investors led the round, which also included Box Group and Allen & Company LLC
2021: Newpath Partners led the financing round with participation from 8VC, Hatteras Venture Partners and Alexandria Venture Investments.
2021: Series B led by Bayer, Amgen’s VC arm as well as Matrix Partners China, Mirae Asset Capital, Ridgeback Capital, Intel Capital, New Enterprise Associates, 8VC and Lux Capital
2021: The series C was led by 8VC, Presight Capital, Peter Thiel, Mubadala Capital, an unnamed sovereign wealth fund, Founders Fund, Gaingels, Luma Bio-IT, Alexandria Venture Investments and Ulysses Diversified Holdings.
Austin, Texas
Orca Bio’s $192 million Series D financing was co-led by Lightspeed Venture Partners and an undisclosed investor. Other new and existing blue-chip investors also participated in the latest round, including 8VC, DCVC Bio, ND Capital, Mubadala Investment Company, Kaiser Foundation Hospitals, Kaiser Permanente Group Trust and IMRF.
Sebastian Caliri, who leads 8VC’s health care team (2025)
Tony Lyons, President, MAHA Action (2025)